Fundies have the term sheet in their hot little hands and are watching closely for a corporate update. Stockbroker Alpine Capital is understood to be on board for the raise. Of note, investor ...

The Australian gold miner will raise equity to close its hedge book after a lackluster March quarter and guidance downgrade.

Moreover, Lamb Weston primarily sources its potatoes from the Columbia Basin and Idaho regions, which boast the highest yields, leading to 10%-20% lower costs per pound. Its position is protected by ...

Instead, Wolfspeed got caught up in the politics and bureaucracy of the Chips Act and a change of administration, and is now left (to switch from land to sea) swimming with the sharks. Ironically or ...

Berkshire Hathaway's stock outperforms with record cash reserves, smart asset allocation, and resilience amidst market ...

It doesn’t need to raise billions or overhaul its business model to justify holding Bitcoin. Instead, it’s incorporating a Bitcoin treasury strategy as part of a disciplined, long-term ... capital ...

We are lowering our fair value estimate to DKK 11,100 from DKK 12,700 per share after factoring in different Trump tariff scenarios. Our new value corresponds to a forward enterprise value/EBITDA ...

The CEO of TMX Group, the operator of the Toronto Stock Exchange, is recommending changes Canada’s next federal government should make to lower barriers for companies looking to raise money ...

China's Giant Biogene has raised about $301 million in a Hong Kong top up placement, according to a term sheet seen by Reuters.

Cue Biopharma (NASDAQ:CUE) announced the pricing details of its underwritten public offering. The offering includes (i) 13,530,780 shares of its common stock, along with warrants to purchase an ...

US$2.2 billion (~CAD$3.01 billion) acquisition expected to be immediately accretive to adjusted funds from operations per share BASE SHELF ...